Revenue | ₹30.67Cr |
Net Profits | ₹4.80Cr |
Net Profit Margins | 15.65% |
Par Drugs & Chemicals Ltd’s revenue jumped 41.66% since last year same period to ₹30.67Cr in the Q3 2025-2026. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 5.25% jump in its revenue since last 3-months.
Par Drugs & Chemicals Ltd’s net profit jumped 727.59% since last year same period to ₹4.80Cr in the Q3 2025-2026. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 16.22% jump in its net profits since last 3-months.
Par Drugs & Chemicals Ltd’s net profit margin jumped 484.19% since last year same period to 15.65% in the Q3 2025-2026. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 10.42% jumped in its net profit margins since last 3-months.
The revenue for Par Drugs & Chemicals Ltd in the Q3 results 2025 was ₹30.67Cr.
The net profit for Par Drugs & Chemicals Ltd in the Q3 results 2025 was ₹4.80Cr.
The net profit margin for Par Drugs & Chemicals Ltd in the Q3 results 2025 was 15.65%.
The revenue for Par Drugs & Chemicals Ltd in the Q3 results 2024 was ₹21.65Cr.
The net profit for Par Drugs & Chemicals Ltd in the Q3 results 2024 was ₹0.58Cr.
The net profit margin for Par Drugs & Chemicals Ltd in the Q3 results 2024 was 2.68%.